Trials / Completed
CompletedNCT06489717
High Altitude Residents With High Altitude Pulmonary Hypertension (HAPH), SDB Assessed at HA (3200 m) vs LA (760 m)
Comparative Study of Sleep Disordered Breathing (SDB) in Patients With High Altitude Pulmonary Hypertension Permanently Residing Above 2500 Meters When Assessed Near Resident High Altitude (HA) at 3200 m vs. at Low Altitude (LA) 760 m
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- University of Zurich · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
To study the effect of relocation from 3200m (Aksay) to 760m (Bishkek) in highlanders with High Altitude Pulmonary Hypertension (HAPH) who permanently live \>2500m on sleep disordered breathing
Detailed description
This research in highlanders with HAPH diagnosed by echocardiography and defined by a RV/RA \>30 mmHg who permanently live at HA \>2500 m will have nocturnal respiratory sleep studies near their living altitude in Aksay at 3200 m and on night 1 and 6 at 760m after relocation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | SDB assessment | SDB will be assessed by respiratory polygraphy according to clinical standards |
Timeline
- Start date
- 2024-07-02
- Primary completion
- 2024-07-12
- Completion
- 2024-07-12
- First posted
- 2024-07-08
- Last updated
- 2026-01-22
Locations
1 site across 1 country: Kyrgyzstan
Source: ClinicalTrials.gov record NCT06489717. Inclusion in this directory is not an endorsement.